Norbert Grząśko
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 49
- Multiple Myeloma Research and Treatments 49
- Oncology 26
- Peptidase Inhibition and Analysis 19
- Cancer Treatment and Pharmacology 4
- Co-authors
- Marek Hus (14 shared papers)Marta Morawska (11 shared papers)Anna Dmoszyńska (15 shared papers)Adam Walter‐Croneck (6 shared papers)Andrzej Pluta (3 shared papers)W Wiktor-Jędrzejczak (7 shared papers)Maria Cioch (3 shared papers)Catriona Byrne (7 shared papers)
- Journals
- Blood (7 papers)International Journal of Cancer (4 papers)Leukemia (3 papers)British Journal of Haematology (3 papers)Hematological Oncology (3 papers)
- Partner nations
- PolandUnited StatesGermany
In The Last Decade
Norbert Grząśko
57 papers receiving 1.9k citations
Norbert Grząśko's Hit Papers
Peers
Comparison fields: 5 of 66
- Hematology 1.5k
- Oncology 709
- Genetics 225
- Molecular Biology 1.1k
- Cancer Research 83
Countries citing papers authored by Norbert Grząśko
This map shows the geographic impact of Norbert Grząśko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Grząśko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Grząśko more than expected).
Fields of papers citing papers by Norbert Grząśko
This network shows the impact of papers produced by Norbert Grząśko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Grząśko. The network helps show where Norbert Grząśko may publish in the future.
Co-authors
The 25 scholars most cited alongside Norbert Grząśko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma Hit paper breakdown → | 2016 | 893 |
| 2 | 2016 | 94 | |
| 3 | 2021 | 69 | |
| 4 | 2014 | 63 | |
| 5 | 2016 | 57 | |
| 6 | 2015 | 54 | |
| 7 | 2011 | 52 | |
| 8 | 2018 | 50 | |
| 9 | 2017 | 44 | |
| 10 | 2012 | 42 | |
| 11 | 2016 | 41 | |
| 12 | 2019 | 36 | |
| 13 | 2018 | 31 | |
| 14 | 2014 | 27 | |
| 15 | 2014 | 26 | |
| 16 | 2018 | 26 | |
| 17 | 2020 | 24 | |
| 18 | 2018 | 20 | |
| 19 | 2025 | 20 | |
| 20 | 2018 | 17 |
About Norbert Grząśko
Norbert Grząśko is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Cancer Research, having authored 58 papers that have together received 1.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (49 papers), Protein Degradation and Inhibitors (23 papers), Peptidase Inhibition and Analysis (19 papers), Chronic Lymphocytic Leukemia Research (7 papers), Ubiquitin and proteasome pathways (5 papers), Cancer Treatment and Pharmacology (4 papers), Peripheral Neuropathies and Disorders (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Hematology (1.5k citations), Oncology (709 citations), Genetics (225 citations), Molecular Biology (1.1k citations) and Cancer Research (83 citations). Norbert Grząśko has collaborated with scholars based in Poland, United States and Germany. Frequent co-authors include Marek Hus, Marta Morawska, Anna Dmoszyńska, Adam Walter‐Croneck, Andrzej Pluta, W Wiktor-Jędrzejczak, Maria Cioch, Catriona Byrne, Zhaoyang Teng and Richard Labotka. Their work appears in journals such as Blood, International Journal of Cancer, Leukemia, British Journal of Haematology and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.